Universal Beteiligungs und Servicegesellschaft mbH Increases Stock Holdings in Rhythm Pharmaceuticals, Inc. $RYTM

Universal Beteiligungs und Servicegesellschaft mbH significantly increased its stake in Rhythm Pharmaceuticals, Inc. during the fourth quarter, purchasing an additional 22,165 shares and bringing its total holdings to 123,537 shares valued at $13.22 million. This move, alongside increased institutional interest from other major investors like Vanguard and AllianceBernstein, highlights growing confidence in the company. Rhythm Pharmaceuticals also reported stronger-than-expected quarterly earnings and revenue, and analysts maintain a “Moderate Buy” rating with an average target price of $131.13.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin